Alexey is a Chief Digital Health Officer of Gero.ai, leading Gerosense.ai, a digital biomarker for measuring biological age and enabling digital trials in humans at a drastically lower cost. Previously Alexey served as co-founder and CEO of Gray Matter. This company was developing therapeutic peptides solving age-related cognitive decline and longevity, CEO of Cryno Biotech, a company developing a novel GLP-1 agonist. Early team member of Insilico Medicine and Centaura. Alexey is a Ph.D. candidate at Vrije University Amsterdam (supervisor - Andrea Meier).